These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37242370)

  • 1. Reliability of E-Tests and the Phoenix Automated Method in Assessing Susceptibility to IV Fosfomycin-Comparative Studies Relative to the Reference Method.
    Kowalska-Krochmal B; Mączyńska B; Smutnicka D; Secewicz A; Krochmal G; Laufer K; Dudek-Wicher R
    Pathogens; 2023 May; 12(5):. PubMed ID: 37242370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Fosfomycin Etest To Determine
    Karlowsky JA; Baxter MR; Golden AR; Adam HJ; Walkty A; Lagacé-Wiens PRS; Zhanel GG
    J Clin Microbiol; 2021 Nov; 59(12):e0163521. PubMed ID: 34495708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance Evaluation of BD Phoenix and MicroScan WalkAway Plus for Determination of Fosfomycin Susceptibility in
    Bondi A; Curtoni A; Peradotto M; Zanotto E; Boattini M; Bianco G; Iannaccone M; Barbui AM; Cavallo R; Costa C
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Clinical Systems for Polymyxin Susceptibility Testing of Clinical Gram-Negative Bacteria in China.
    Zhu Y; Jia P; Zhou M; Zhang J; Zhang G; Kang W; Duan S; Wang T; Xu Y; Yang Q
    Front Microbiol; 2020; 11():610604. PubMed ID: 33692761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter Evaluation of the Novel ETEST Fosfomycin for Antimicrobial Susceptibility Testing of Enterobacterales, Enterococcus faecalis, and Staphylococcus Species.
    Goer A; Blanchard LS; Van Belkum A; Loftus KJ; Armstrong TP; Gatermann SG; Shortridge D; Olson BJ; Meece JK; Fritsche TR; Pompilio M; Halimi D; Franceschi C
    J Clin Microbiol; 2022 Jul; 60(7):e0002122. PubMed ID: 35736011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of staphylococci and enterococci.
    Carroll KC; Borek AP; Burger C; Glanz B; Bhally H; Henciak S; Flayhart DC
    J Clin Microbiol; 2006 Jun; 44(6):2072-7. PubMed ID: 16757600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa.
    Mojica MF; De La Cadena E; Hernández-Gómez C; Correa A; Appel TM; Pallares CJ; Villegas MV
    J Glob Antimicrob Resist; 2020 Jun; 21():391-395. PubMed ID: 32004722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of fosfomycin resistance in Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections.
    Kansak N; Arıcı N; Adaleti R; Nakipoglu Y; Aksaray S
    J Microbiol Methods; 2021 Sep; 188():106296. PubMed ID: 34333048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the Susceptibility of Clinical Gram-Negative and Gram-Positive Bacterial Strains to Fosfomycin and Significance of This Antibiotic in Infection Treatment.
    Kowalska-Krochmal B; Mączyńska B; Rurańska-Smutnicka D; Secewicz A; Krochmal G; Bartelak M; Górzyńska A; Laufer K; Woronowicz K; Łubniewska J; Łappo J; Czwartos M; Dudek-Wicher R
    Pathogens; 2022 Nov; 11(12):. PubMed ID: 36558775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance Evaluation of BD Phoenix NMIC-413 Antimicrobial Susceptibility Testing Panel for Imipenem, Meropenem, and Ertapenem Against Clinical Carbapenem-Resistant and Carbapenem-Susceptible
    Zhang J; Jia P; Zhu Y; Zhang G; Xu Y; Yang Q
    Front Med (Lausanne); 2021; 8():643194. PubMed ID: 33937287
    [No Abstract]   [Full Text] [Related]  

  • 11. Gold standard susceptibility testing of fosfomycin in Staphylococcus aureus and Enterobacterales using a new agar dilution panel®.
    Campanile F; Wootton M; Davies L; Aprile A; Mirabile A; Pomponio S; Demetrio F; Bongiorno D; Walsh TR; Stefani S; Mezzatesta ML
    J Glob Antimicrob Resist; 2020 Dec; 23():334-337. PubMed ID: 33127523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter Clinical Evaluation of Vitek 2 Meropenem-Vaborbactam for Susceptibility Testing of
    Dwivedi HP; Franklin S; Chandrasekaran S; Garner O; Traczewski MM; Beasley D; Procop GW; Tuohy M; Wilson D; Bala Y; Pincus DH
    J Clin Microbiol; 2022 Jan; 60(1):e0161021. PubMed ID: 34705536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of ESBL Escherichia coli and Klebsiella pneumoniae to fosfomycin in the Netherlands and comparison of several testing methods including Etest, MIC test strip, Vitek2, Phoenix and disc diffusion.
    van den Bijllaardt W; Schijffelen MJ; Bosboom RW; Cohen Stuart J; Diederen B; Kampinga G; Le TN; Overdevest I; Stals F; Voorn P; Waar K; Mouton JW; Muller AE
    J Antimicrob Chemother; 2018 Sep; 73(9):2380-2387. PubMed ID: 29982660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Susceptibility of Multi-Drug Resistant
    Mączyńska B; Paleczny J; Oleksy-Wawrzyniak M; Choroszy-Król I; Bartoszewicz M
    Pathogens; 2021 Apr; 10(5):. PubMed ID: 33922754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Commercial Products for Colistin and Polymyxin B Susceptibility Testing for
    Zhang Q; Yan W; Zhu Y; Jing N; Wang S; Yuan Y; Ma B; Xu J; Chu Y; Zhang J; Ma Q; Wang B; Xu W; Zhu L; Sun Y; Shi C; Fang J; Li Y; Liu S
    Infect Drug Resist; 2023; 16():1171-1181. PubMed ID: 36875227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Evaluation of Seven Tigecycline Susceptibility Testing Methods for Carbapenem-Resistant
    Li H; Zhou M; Chen X; Zhang Y; Jian Z; Yan Q; Liu WE
    Infect Drug Resist; 2021; 14():1511-1516. PubMed ID: 33907429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of BD phoenix to vitek 2, microscan MICroSTREP, and Etest for antimicrobial susceptibility testing of Streptococcus pneumoniae.
    Mittman SA; Huard RC; Della-Latta P; Whittier S
    J Clin Microbiol; 2009 Nov; 47(11):3557-61. PubMed ID: 19741088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Piperacillin-Tazobactam Testing against
    Manuel C; Maynard R; Abbott A; Adams K; Alby K; Sweeney A; Dien Bard J; Flores II; Rekasius V; Harrington A; Kidd TS; Mathers AJ; Tekle T; Simner PJ; Humphries RM
    J Clin Microbiol; 2023 Feb; 61(2):e0161722. PubMed ID: 36719243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of BD Phoenix and Microscan WalkAway for determination of fosfomycin susceptibility in Staphylococcus aureus.
    Bondi A; Peradotto M; Bianco G; Ghibaudo D; Barbui AM; Costa C; Cavallo R
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115240. PubMed ID: 33465684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the BD Phoenix M50 Automated Microbiology System for Antimicrobial Susceptibility Testing with Clinical Isolates in Korea.
    Hong JS; Kim D; Kang DY; Park BY; Yang S; Yoon EJ; Lee H; Jeong SH
    Microb Drug Resist; 2019 Oct; 25(8):1142-1148. PubMed ID: 31161952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.